BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 15068981)

  • 1. Vitamin C pharmacokinetics: implications for oral and intravenous use.
    Padayatty SJ; Sun H; Wang Y; Riordan HD; Hewitt SM; Katz A; Wesley RA; Levine M
    Ann Intern Med; 2004 Apr; 140(7):533-7. PubMed ID: 15068981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.
    Duconge J; Miranda-Massari JR; Gonzalez MJ; Jackson JA; Warnock W; Riordan NH
    P R Health Sci J; 2008 Mar; 27(1):7-19. PubMed ID: 18450228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenously administered vitamin C as cancer therapy: three cases.
    Padayatty SJ; Riordan HD; Hewitt SM; Katz A; Hoffer LJ; Levine M
    CMAJ; 2006 Mar; 174(7):937-42. PubMed ID: 16567755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers.
    Slain D; Amsden JR; Khakoo RA; Fisher MA; Lalka D; Hobbs GR
    Pharmacotherapy; 2005 Feb; 25(2):165-70. PubMed ID: 15767232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic data support 6-hourly dosing of intravenous vitamin C to critically ill patients with septic shock.
    Hudson EP; Collie JT; Fujii T; Luethi N; Udy AA; Doherty S; Eastwood G; Yanase F; Naorungroj T; Bitker L; Abdelhamid YA; Greaves RF; Deane AM; Bellomo R
    Crit Care Resusc; 2019 Dec; 21(4):236-42. PubMed ID: 31778629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats.
    Egorin MJ; Yuan ZM; Sentz DL; Plaisance K; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 43(6):445-53. PubMed ID: 10321503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascorbic acid concentrations in aqueous humor after systemic vitamin C supplementation in patients with cataract: pilot study.
    Hah YS; Chung HJ; Sontakke SB; Chung IY; Ju S; Seo SW; Yoo JM; Kim SJ
    BMC Ophthalmol; 2017 Jul; 17(1):121. PubMed ID: 28693452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients. How vitamin C is administered affects how much reaches the bloodstream and may affect the results of studies of its potential effect on cancer.
    Ann Intern Med; 2004 Apr; 140(7):I61. PubMed ID: 15069006
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers.
    Cass LM; Efthymiopoulos C; Bye A
    Clin Pharmacokinet; 1999; 36 Suppl 1():1-11. PubMed ID: 10429835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
    Bramer SL; Forbes WP; Mallikaarjun S
    Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin C Pharmacokinetics in Critically Ill Patients: A Randomized Trial of Four IV Regimens.
    de Grooth HJ; Manubulu-Choo WP; Zandvliet AS; Spoelstra-de Man AME; Girbes AR; Swart EL; Oudemans-van Straaten HM
    Chest; 2018 Jun; 153(6):1368-1377. PubMed ID: 29522710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ascorbic acid concentrations in previously unsupplemented greyhounds after administration of a single dose of ascorbic acid intravenously or per os.
    Scott KC; Hill RC; Lewis DD; Gronwall R; Sundstrom DA; Jones GL; Harper J
    J Anim Physiol Anim Nutr (Berl); 2002 Aug; 86(7-8):222-8. PubMed ID: 15379908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
    Gordi T; Tan LH; Hong C; Hopkins NJ; Francom SF; Slatter JG; Antal EJ
    J Clin Pharmacol; 2003 Oct; 43(10):1161-7. PubMed ID: 14517199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of ascorbic acid to horses.
    Snow DH; Gash SP; Cornelius J
    Equine Vet J; 1987 Nov; 19(6):520-3. PubMed ID: 3504762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose vitamin C supplementation increases skeletal muscle vitamin C concentration and SVCT2 transporter expression but does not alter redox status in healthy males.
    Mason SA; Baptista R; Della Gatta PA; Yousif A; Russell AP; Wadley GD
    Free Radic Biol Med; 2014 Dec; 77():130-8. PubMed ID: 25242204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.